Trending Sources

Xconomy Special Report: 12 San Diego Tech Startup to Watch in 2017


View the Slideshow A little more than a year ago, amid a resurgence in San Diego’s software sector, Xconomy identified a baker’s dozen of local tech companies to watch in 2016. Four of the companies on this year’s list also reflect how San Diego’s tech and life sciences communities have been coming together in interesting ways.

Santa Barbara, San Diego Tops On Per-Capita Venture Capital


San Diego-Carlsbad-San Marcos was number 7, with $36.6M in deals and 3.3 San Jose-Sunnyvale-Santa Clara; 2. READ MORE>>.

San Diego Startups Raise $287M in Third Quarter, and Top 10 Deals


Venture Capital investments in San Diego startups fell by roughly a third during the three months that ended September 30, according to data released recently by Seattle-based PitchBook and the National Venture Capital Association. As Xconomy reported last week , third-quarter venture funding also slipped nationwide to $14.99

San Diego Innovation Economy Extended Gains in 2015: Connect Report


That’s according to a report being released today by Connect, the local nonprofit group focused on technology and entrepreneurship.

Web 9

Q2 VC Funding Soars in San Diego (After Revisions), and Top 10 Deals


But the San Diego data was off. million in 19 companies in San Diego. million invested in 23 San Diego companies.

Two San Diego Sites Rank Tops In Rising Social Networking Interest


Image courtesy Bigstock. READ MORE>>. social networking analysis pinterest experian skillwho stocktwits ranking

Synthetic Genomics Creates Host Organism Optimized for Bio Industry


According to the company, the findings reported today set the stage for commercialization of Vmax cells for molecular cloning and protein expression.

Avelas Bio Raises $20M to Push Cancer-Illuminating Biologic Agent


and San Diego’s Avalon Ventures. The first-in-human trials of AVB-620 began last year at UC San Diego’s Moores Cancer Center.

Study 36

Dauntless Takes Flight with New Business Model for Starting Biotechs


All of the company’s funding so far has come from Sofinnova Ventures, and Mike Powell, a Sofinnova general partner in San Francisco, is board chairman.

At “The Vine,” Developer Builds a Vertical Campus for Tech Startups


In San Diego, the Irvine Company provided the entire second floor of its Broadway Street building at no cost for the downtown EvoNexus incubator.

San Diego Sees Strong Cybersecurity Growth As Firms Seek Talent


San Diego’s cybersecurity workforce has grown by nearly 15 percent over the past two years, according to a study released today by the Cyber Center of Excellence, a nonprofit industry group created to boost cybersecurity jobs and technologies in the region. The center also asked the San Diego Regional Economic Development Corp.

Websense, After Move From San Diego, In Acquisition Talks


Former San Diego-based security software developer Websense > --one of a number of companies acquired by private equity investor Vista Equity Partners and moved out of San Diego--is now in talks to be acquired by Raytheon , according to a report. Websense was acquired by Vista Equity Partners in 2013. READ MORE>>.

Immunotherapy Clinical Tests Spur Hope, and Plenty of Headaches


Aduro reported in May that more dropouts than expected scuttled the trial. Blinding many studies is futile, say clinicians.

Study 32

Nervana’s $400M+ Buyout Reflects Key Tech Trend in Machine Learning


Nervana, which now has 48 employees, plans to remain in San Diego and operate under its own brand name.

San Diego's Mapp Bio Behind Experimental Ebola Drug


A San Diego-based biopharmaceuticals startup, Mapp Biopharmaceuticals , is the source of the experimental Ebola treatment that has been given to the two Americans who are being treated for the dreaded disease, according to CNN. Mapp Biopharmaceutical is backed by LeafBio, Defyrus Inc., the U.S. READ MORE>>.

Texas Looks To Steal Away Another San Diego Company, Omnitracs


According to reports, Omnitracs is in the midst of negotations to move its operations out of San Diego, and to Austin, following the recent sale of Omnitracs by Qualcomm to private equity firm Vista Equity Partners. texas diego omnitracs jobs employment READ MORE>>.

14 for ’17: Key Clinical Data To Watch For Next Year (Part 2)


Editor’s note: Ben Fidler and Frank Vinluan contributed to this report.] We continue our look ahead to some of the clinical data due in 2017 that could shape healthcare practice and sway investor sentiment for years to come. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

IBM Watson Health Launches Imaging Effort for Cancer, Other Diseases


That means doctors should be able to use Watson to read and digest health records, lab results, radiology reports, and relevant medical literature.

IBM 36

Report: Amazon Launching New Game Studio In San Diego

socalTECH is launching a new game studio in San Diego, according to reports , in an effort being led by former Sony Online Entertainment chief John Smedley. amazon game studio diego videogame content hollywood john smedley sony online entertainmentREAD MORE>>.

New U.S. “Roadmap” Lays Out Routes to Accelerate Robotic Technologies


His talk amounted to a state-of-the-industry report on robotics, and highlighted key findings of the 107-page update of the U.S.

BlackThorn Emerges With $40M, New Weapons Against Neuro Disorders


Today they’re finally shedding a little light on what they’ve been up to. Today, BlackThorn is making its first formal announcement. It’s similar here.

All In One Place: A New Immuno-Oncology Trial Resource


As reporters, we find that frustrating. The infections were turbo-charging the immune system. Perhaps you do, too.

New Data Show Biogen, Ionis Drug Might Help More With Rare Spine Disease


But new data released this morning show that the therapy, known as nusinersen (Spinraza), could have a much broader reach. points.

Study 27

Drug-Hunting Startup From Scripps Attracts Celgene Alum, $50M Backing


A team of decorated academic chemists in San Diego have been working since 2014 on a biotech startup that aims to find new drugs faster.

Biogen Buys Ionis Spine Disease Drug For $75M, Eyes FDA Filing


Spinal muscular atrophy affects over 25,000 people in the U.S. and stops many of them from ever being able to walk.

Study 29

Duchenne Lessons: Advocates For Rare Spinal Disease Have Eyes on FDA


Heather and Jessica Tomko will tell you that they’re nothing alike. They’ve got different interests, different tastes in movies, television, and music.

The Five Major Tech Trends of 2016


To augment and overcome physical distance, we are starting to use drones, virtual reality, and driverless cars. percent of digital buyers in the U.S.

New Report Details Technology Job Concentration In Region


The highest ranked was San Diego-Carlsbad-San Marcos , with 11.1 percent of jobs in technology, ranked at 20. READ MORE>>.

Biotech Roundup: Hellos, Goodbyes, “Cures” Delays And Trial News


Our San Diego editor Bruce Bigelow penned a personal goodbye to entrepreneur Larry Bock, who died last week of pancreatic cancer at the age of 56. —South San Francisco-based Second Genome hired a new CEO and president. The week started on a reflective note. And perhaps most important, there was the U.S. Or not.

News 28

Despite Low Crop Prices, Corporate and VC Agtech Investments Soar


The increase in dollars flowing to agtech comes despite commodity prices that are down 65 percent from their 2013 peak, the report says.

Bio Roundup: Trump’s Rx Silence, PCSK9 News, Amgen’s Migraines & More


president’s intent to make good on his angry campaign rhetoric on drug prices, while the Associated Press reported that naming-and-shaming—that is, Congress hauling executives into hearings and penning angry letters—certainly hasn’t done the trick. Speculation swirled this week around the incoming U.S.

Press 19

Trump’s Election Stunner: Tech and Life Sciences Leaders React


” Xconomy’s editors contributed to this report. Still processing what this will mean for technology, business, society, and humanity—I guess it’s going to take a while. In the meantime, here are 10 notable reactions from around the Xconomy network, mostly via Twitter. ” 2. That’s my plan.” ” 3.

Notes From The JPM ’17 Vortex: Trump, Rainstorms & The Price You Pay


[ Editor’s note: Ben Fidler contributed to this report ] The week of frenetic data sharing, deal talking, and party hopping of the J.P. Morgan Healthcare Conference—and the events that have mushroomed around it—took a punch to the gut just as most attendees were wrapping up and checking their outbound flight status.

Press 15

Bio Roundup: FDA Says No, PCSK9 Value Fight, CRISPR Intrigue & More


The CRISPR news this week doesn’t need a metaphor; the drama that MIT Technology Review reported can stand alone. — MIT Technology Review reported this week that a graduate student in the lab of Feng Zhang, Broad Institute gene-editing star, had accused the Broad of misleading the U.S. Talk about sacrifice.

The Xconomy Immuno-Oncology Resource: A Mid-ASH T Cell Update


Xconomy reported last week on the new use of these cells to treat multiple myeloma.

Regulus Shares Crumble As FDA Halts Testing of Hepatitis C Drug


Regulus reported that a second serious case of jaundice, or a yellowing of the skin and eyes, in a Phase 1 study of RG-101.

Study 15

Third-Quarter Report Shows Slowdown in VC Activity, & Top 10 Deals


Venture capital activity is gradually easing from last year’s peak, according to a new quarterly report put together by Seattle-based PitchBook and the National Venture Capital Association. deals (1,796 companies) during the third quarter that ended September 30, according to the inaugural “Venture Monitor” report released today.

Bio Roundup: RIP Roger Tsien, Novartis CAR-T Wheel, Zika News & More


Nobel Prize winner Roger Tsien, a UC San Diego chemist, passed away in Oregon this week. As the San Diego Union Tribune reported in 2013, Tsien (pictured) was also unafraid to shine the spotlight on what he considered suspect scientific approaches, even when espoused by legends like DNA co-discoverer James Watson.

Social Fund-raising Website GoFundMe Buys Detroit Rival CrowdRise


Brad Damphousse and Andy Ballester founded GoFundMe in San Diego in 2010. They departed in 2015, after selling a majority stake to an investor group led by Accel and Technology Crossover Ventures that reportedly valued GoFundMe at $600 million. Financial terms were not disclosed in a statement issued Tuesday by GoFundMe.

Pharma’s Productivity Problem: Finding More Blockbuster Drugs


recent Silicon Valley Bank report noted that large corporations have dramatically increased pre-clinical acquisitions in the last three years under the pressure of limited supply and competition from IPOs.  The authors made the point that, given the size of companies today, a single garden-variety blockbuster hardly moves the needle.